Skip to main content
TipRanks
Go Ultimate75% OFF

Bio View (BIOV) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Bio View has a market cap or net worth of ILA 7.54M. The enterprise value is ILA 11.95T.

Market Cap
ILA 7.54M
Enterprise Value
ILA 11.95T

Share Statistics

Bio View has 155,367 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
155,367
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Bio View’s return on equity (ROE) is -1.63 and return on invested capital (ROIC) is -62.01%.

Return on Equity (ROE)
-1.63
Return on Assets (ROA)
-0.77
Return on Invested Capital (ROIC)
-62.01%
Return on Capital Employed (ROCE)
-0.69
Revenue Per Employee
664.33K
Profits Per Employee
-511.07K
Employee Count
30
Asset Turnover
1.00
Inventory Turnover
1.84

Valuation Ratios

The current PE Ratio of Bio View is -0.51. Bio View’s PEG ratio is 0.02.

PE Ratio
-0.51
PS Ratio
0.36
PB Ratio
0.99
Price to FCF
15.29
Price to Operating Cash Flow
12.88
PEG Ratio
0.02

Income Statement

In the last 12 months, Bio View had revenue of 19.93M and earned -15.33M in profits. Earnings per share was -110.00.

Revenue
19.93M
Gross Profit
8.75M
Operating Income
-7.80M
Pretax Income
-9.15M
Net Income
-15.33M
EBITDA
-7.19M
Earnings Per Share (EPS)
-110.00

Cash Flow

In the last 12 months, operating cash flow was 518.00K and capital expenditures -25,000, giving a free cash flow of 493.00K billion.

Operating Cash Flow
518.00K
Free Cash Flow
493.00K
Free Cash Flow per Share
3.58

Dividends & Yields

Bio View pays an annual dividend of ILA 200.00, resulting in a dividend yield of ―

Dividend Per Share
ILA 200.00
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
6.54%
Earnings Yield
-196.39%

Stock Price Statistics

Beta
0.22
52-Week Price Change
-64.85%
50-Day Moving Average
6655.42
200-Day Moving Average
11732.75
Relative Strength Index (RSI)
38.27
Average Volume (3m)
3,183

Important Dates

Bio View upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date
―
Next Earnings Date
―
Ex-Dividend Date
Mar 22, 2017

Financial Position

Bio View as a current ratio of 1.88, with Debt / Equity ratio of 29.67%

Current Ratio
1.88
Quick Ratio
1.17
Debt to Market Cap
0.06
Net Debt to EBITDA
0.30
Interest Coverage Ratio
-33.63

Taxes

In the past 12 months, Bio View has paid 6.18M in taxes.

Income Tax
6.18M
Effective Tax Rate
-0.68

Enterprise Valuation

Bio View EV to EBITDA ratio is -1.29, with an EV/FCF ratio of 8.00.

EV to Sales
0.19
EV to EBITDA
-1.29
EV to Free Cash Flow
8.00
EV to Operating Cash Flow
7.61

Balance Sheet

Bio View has ILA 8.17M in cash and marketable securities with ILA 2.10M in debt, giving a net cash position of ILA 6.07M billion.

Cash & Marketable Securities
ILA 8.17M
Total Debt
ILA 2.10M
Net Cash
ILA 6.07M
Net Cash Per Share
ILA 39.06
Tangible Book Value Per Share
ILA 48.81

Margins

Gross margin is 49.29%, with operating margin of -23.34%, and net profit margin of -63.32%.

Gross Margin
49.29%
Operating Margin
-23.34%
Pretax Margin
-30.16%
Net Profit Margin
-63.32%
EBITDA Margin
-14.81%
EBIT Margin
-23.16%

Analyst Forecast

The average price target for Bio View is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
15.77%
EPS Growth Forecast
-31.40%